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Summary
This paper applies the inverse probability weighted (IPW) least-squares method to estimate the effects of treatment
on total medical cost, subject to censoring, in a panel-data setting. IPW pooled ordinary-least squares (POLS) and
IPW random effects (RE) models are used. Because total medical cost might not be independent of survival time
under administrative censoring, unweighted POLS and RE cannot be used with censored data, to assess the effects of
certain explanatory variables. Even under the violation of this independency, IPW estimation gives consistent
asymptotic normal coefficients with easily computable standard errors. A traditional and robust form of the
Hausman test can be used to compare weighted and unweighted least squares estimators. The methods are applied to
a sample of 201 Medicare beneficiaries diagnosed with lung cancer between 1994 and 1997. Copyright# 2006 John
Wiley & Sons, Ltd.
JEL classification: C23; I1
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Introduction
Rising health care expenditures in many indus-
trialized countries has spurred the development of
methods for analysis of medical costs in conjunc-
tion with evaluation of health outcomes. Chal-
lenges in analyzing cost data include addressing
skewness in cost distributions, heterogeneity
across samples and more challenging, complexities
due to censoring.
Ordinary least squares estimation (OLS) can be
used to analyze cost data under exogenous
censoring. With exogenous censoring, once cov-
ariates have been selected, the total cost Y over the
period T (survival time) are assumed independent.
With longitudinal data, administrative censoring is
due to study termination when, for instance, the
analyst chooses a closing date for data collection.
In these circumstances, OLS is not appropriate
because total costs and survival time are likely to
be associated. Because longer survival times and
their associated costs are more likely to be
censored, estimates of cost based only on the
uncensored cases are biased towards patients with
shorter survival times.
In this paper, we apply an inverse probability
weighted (IPW) least squares method to assess the
effects of covariates (e.g. patient and clinical
characteristics) on medical cost with censored
data. In our application to costs in patients
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diagnosed with lung cancer, we aim to observe the
effects of treatment on average cost per subperiod
(e.g. monthly, quarterly) over a circumscribed
window of observation. In particular, our method
examines how various treatment regimens (e.g.
surgery only, chemotherapy, radiation and combi-
nations of surgery, chemotherapy, and radiation)
affects the cost of lung cancer care per month over
the two years of initial diagnosis.
The IPW least squares method has a long
history in statistics [1–6]. Our work is strongly
influenced by the more general framework that
develops the asymptotic properties of the IPW
M-estimator for variable probability samples [7, 8].
IPW least squares produces consistent asymptoti-
cally normal coefficients with easily computable
standard errors, even under violation of the
exogenous censoring assumption.
Other published applications of IPW estimation
included Lin [9, 10] Jain and Strawderman [11] and
Willan et al. [12]. Lin [9, 10] developed a method to
estimate the mean cost conditional on covariates
from data subject to censoring. Jain and Strawder-
man [11] extend Lin’s method to implement
inverse probability of censoring weighted estima-
tion in a hazard regression model for the condi-
tional distribution of life time cost given
covariates. Both of these methods analyze the
cross-sectional data. Willan et al. [12] proposed an
extension of Lin’s methods to allow for long-
itudinal structure for cost effectiveness analysis. In
particular, the researchers use seemingly unrelated
regression (SUR) equations when comparing two
groups in a cost effectiveness analysis. In contrast,
our model controls for both continuous and
several categorical time dependent variables,
whereas Willan et al. [12] have only one categorical
time dependent variable.
Another popular approach in the health services
literature is to create a measure of cost per-
individual per-month from longitudinal data on
expenditures over the period of cost accumulation.
Our proposed method is based on panel data.
Thus, it differs from that of Lin [9,10] and Jain and
Strawderman [11]. Using data gathered over time
from the same cross sectional units is useful for
several reasons. First, it allows us to examine
dynamic relationships, which is not possible with a
single cross section. Second, the panel data
structure extends Lin’s method to accommodate
covariates that are time dependent.
The panel data model is conceptually different
from the SUR model. The errors, for example, are
homoskedastic and serially independent both
within and between individuals. In SUR models
the errors are allowed to be contemporarily
correlated and heteroskedastic between indivi-
duals. If there are a large number of independent
individuals observed (more than 500) for a few
time periods (less than 30), it is not possible to
estimate different individual slopes for all the
exogeneous variables. Panel data are not subject to
these restrictions.
None of the previous work using IPW methods
offers a test to compare their methodology with
potential bias methods. As a secondary contribu-
tion, we show how to apply a traditional and
robust form of the Hausman test [13] to determine
if systematic differences are present between OLS
and IPW least squares methods. This allows us to
determine whether bias introduced by applying
OLS on the uncensored data leads to statistically
significant differences in the coefficients.
We first introduce IPW pooled ordinary least
squares (POLS) and IPW random effects (RE)
models. The choice between the two models is
dependent upon the presence of unobserved
heterogeneity in the data. The next section
describes the proposed Hausman type of test. We
demonstrate our methods for assessing covariate
effects on costs using data from Medicare claim
files for a sample of patients diagnosed with lung
cancer. Further, we present the detail of applica-
tion. The final section summarizes our findings. All
technical details are presented in Appendix A.
General framework
Suppose that we are interested in the total medical
cost over period ½0;L. If there are data on cost and
explanatory variables at multiple intervals such as
months or years, they fit naturally into a panel
format. Let the entire time period of interest be
divided into G intervals: 0 ¼ t05t15   5tG ¼ L.
Since there is no further medical expense after
death, the total cost over ðtg1; tg is the same as
the cost incurred up to Tng ¼ minðT ; tgÞ, where T is
the survival time. The distribution of T is assumed
to be continuous from 0 to L.
Survival time and medical cost may be subject to
right censoring and therefore are not always fully
observable. Censoring of cost occurs when a
patient’s follow-up time is less than tG, and the
patient is alive at the time of censoring. Because no
Copyright # 2006 John Wiley & Sons, Ltd. Health Econ. 15: 513–525 (2006)
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further expense is incurred after death, for all
observed deaths the total costs are known.
One advantage of dividing the total period into
intervals is that we can consider the ith individual
as uncensored in the gth interval ðtg1; tg whenever
the censoring time C exceeds the minimum of T
and tg. Therefore, some individuals regarded as
censored in studies which we do not partition the
period of interest can be considered uncensored in
some intervals during the period of interest.
For the ith individual let Tni ¼ minðTi;LÞ, Zi ¼
minðTni ;CiÞ and sig ¼ IðCi  T
n
igÞ, where Ið:Þ is the
indicator function. Therefore, cost in the gth
interval is censored if sig ¼ 0.
Let yig be the medical cost (or log-transformed
cost) for the ith individual in the interval ðtg1; tg.
If there is an initial cost at t ¼ 0, we include that
cost in first time interval. The following situations
arise:
(a) Zi  tg: Here the patient survives beyond tg
and is not censored by time tg. Therefore yig is
observed.
(b) Zi  tg1 and sig ¼ 1: If death occurs in
ðtg1; tg then Ti is observed. The period costs
yig in ðtg1;T  is observed. If death does not
occur in ðtg1; tg then we are back to (a).
(c) Zi  tg1 and sig=0: Here censoring occurs in
ðtg1; tg and the cost yig is censored.
(d) Zi5tg1: Either death or censoring precedes
tg1. Therefore, the cost yig in ðtg1; tg is either
zero (if death had occurred) or is censored.
(a)–(d) captures all possibilities. For example, if
our study is 12 months and costs are assessed
monthly, then an observed death in month 1
would mean that yitð 0Þ is observed, and yi2 ¼
   ¼ yi12 ¼ 0 for the next 11 months. According
to our model we will use all the yig’s as long as
sig ¼ 1. This is true for the POLS estimator #bup and
IPW POLS estimator #bwp that we describe next.
The asymptotic theory of the estimators #bup and
#bwp still hold true, although one could claim that
we could do better modelling the zero-cost
observations. We will mention this again after
introducing our random effects model.
Pooled ordinary least squares estimation
(POLS)
The properties of POLS under exogenous censor-
ing can be summarized as follows. Assume the
usual linear model for independent identically
distributed cross-sections: for each i
yi ¼ Xibþ ui i ¼ 1; 2; . . . ;N
where Xi ¼ ðx0i1;x
0
i2; . . . ;x
0
iGÞ
0 is G K matrix of
explanatory variables, b is the K  1 vector of
unknown regressions parameters, ui is G 1
vector of unobservables whose distribution is
unspecified. Let Si be a G G matrix whose gth
diagonal element sig ¼ 1 if ðxig; yigÞ is observed,
zero otherwise. Generally, we have an unbalanced
panel. We can define our explanatory variables
and response variables for the selected sample as
*Xi ¼ SiXi, *yi ¼ Siyi.
Assumption 1.
(i) Eðui jXiÞ ¼ 0;
(ii) Eðui jXiÞ ¼ Eðui jXi;SiÞ;
(iii) Eð *X0i *XiÞ has rank K .
Under assumption 1, the unweighted POLS
estimator #bup of b
#bup ¼ N1
XN
i¼1
*X0i
*Xi
 !1
N1
XN
i¼1
*X0i*yi
 !
is consistent, asymptotically normal with its
asymptotic robust variance matrix estimated by
#Vup ¼ #A1up #Bup #A
1
up =N
where
#Aup ¼ N1
XN
i¼1
*X0i
*Xi
 !
#Bup ¼N1
XN
i¼1
*X0ið
%
*uiÞð
%
*uiÞ
0 *Xi
and
%
*ui ¼ *yi  *Xi #bup.
Assumption 1(ii) is the key exogenous censoring
assumption underlying the validity of the
unweighted POLS estimator from the censored
sample. This assumption is not true in the
estimation of medical cost from administratively
censored data, because assumption 1(ii) entails,
for all g
Eðyigjxig; sigÞ ¼ EðyigjxigÞ ð1Þ
Under administrative censoring, although Ci and
yig are independent, yig and Ti could be correlated.
We will see that IPW least squares estimation
produces a consistent, asymptotically normal
estimator of b even when (1) does not hold, but
Longitudinal Analysis of CensoredMedical Cost Data 515
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under the following assumptions. Suppose that T
and C are independent given x.
Assumption 10.
(i) EðX0iuiÞ ¼ 0;
(ii) Eð *X0i *XiÞ has rank K;
(iii) xig and yig are ignorable in the censoring
equation, that is
Pðsig ¼ 1jxig; yig;TiÞ
¼A PðCi  Tnigjxig; yig;TiÞ
¼B PðCi  minðtig;LÞjxig; yig;TiÞ
¼C Pðsig ¼ 1jTiÞ
A is the definition of sig ¼ 1; B is the definition of
Tnig; C is a consequence of the assumption that the
censoring time Ci is independent of ðxig; yig;TiÞ and
L is constant. For similar formats see for example
Lin [9]. We observe Ti whenever Ti is uncensored,
we observe Ci when si ¼ 0. A weaker assumption
would be that the censoring time Ci is independent
of ðyig;TiÞ given xig. The censoring probability is
then Pðsig ¼ 1jxig; yig;TiÞ ¼ Pðsig ¼ 1jTiÞ.
Another advantage of weighting the observa-
tions, other than solving the censoring problem,
is that we derive consistency with the weaker
assumption 10(i) rather than assumption 1(i).
Assumption 10(ii) is the appropriate rank condi-
tion. Assumption 10(iii) requires that the censoring
probability is observable when sig ¼ 1.
Under Assumption 10 the IPW POLS estimator
is, #bwp
#bwp ¼ #A1wp N
1
XN
i¼1
#X0i #yi
 !
where
#Awp ¼ N1
XN
i¼1
#X0i
#Xi
 !
#Xi ¼ SiP1i Xi, #yi ¼ SiP
1
i yi, and Pi is G G
diagonal matrix in which the gth diagonal element
is
ffiffiffiffiffi
pig
p
where
pig ¼ PðCi  TnigjTiÞ ¼ pðT
n
igÞ ð2Þ
and pðtÞ ¼ P½Ci  t. Then, #bwp is consistent,
asymptotically normal and its asymptotic robust
variance matrix is estimated by
#Vwp ¼ #A1wp #Bwp #A
1
wp=N ð3Þ
where
#Bwp ¼ N1
XN
i¼1
#X0ið#uiÞð#uiÞ
0 #Xi
and #ui ¼ #yi  #Xi #bwp.
Each observation of ðyi;xiÞ is weighted by the
inverse probability of appearing in the sample.
Assumption 10(iii) requires the function pðtÞ to be
known, so #bwp is computable from observed data.
The estimated covariance matrix in (3) is the
White heteroskedasticity-robust covariance matrix
[14] applied to all variables for observation i in the
gth interval and weighted by the inverse prob-
ability of appearing in the sample. Hence, under
our assumptions censoring can be handled fairly
easily because most standard statistics software
programs compute a heteroskedasticity-robust
covariance matrix.
Usually the sampling probability function, pig, is
unknown and needs to be estimated. Assume a
parametric form pðt; yÞ for pðtÞ is known except for
the unknown y. Let si ¼ IðCi  Tni Þ. Using the
sample, fðZi; %siÞ : i ¼ 1; . . . ;Ng where %si ¼ 1 si,
we construct a consistent estimator #pðtÞ ¼ pðt; #yÞ of
pðtÞ. Then,
#pig ¼ #pðTnig; #yÞ; i ¼ 1; . . . ;N; g ¼ 1; . . . ;G ð4Þ
Application of Lemma 4.3 in [15] shows that if pig
in (2) is replaced by #pig, under the conditions in
which the uniform weak law of large numbers can
be applied, then #bwp consistently estimates b.
Except where censoring is exogenous, one should
adjust the variance matrix in (3) to account for the
first stage estimation of censoring probabilities.
The adjusted variance matrix is given in (A7) in
Appendix A.
Random effects model
Panel data usually provide researchers with a large
number of data points that increase the degrees of
freedom and reduce collinearity among explana-
tory variables. It also provides a way to resolve or
reduce the magnitude of an econometric problem
that often arises in empirical studies, namely,
omitted variables that are correlated with expla-
natory variables. One has greater flexibility in
controlling for the effects of unobserved variables
by using information on both the intertemporal
dynamics and the individuality of the entities being
investigated [16].
O. Bas,er et al.516
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Let us first investigate assumptions under which
the random effects estimator is consistent under
exogenous censoring. The model is the unobserved
effects model for any i and all G time periods
yi ¼ Xibþ vi ð5Þ
where Xi is G K , b is K  1, and vi is the vector
of composite errors, aijG þ ui, where ai is the
unobserved heterogeneity and jG is G 1 vector
with all entries equal to 1.
Assumption 2.
(i) EðvijXiÞ ¼ 0;
(ii) EðvijXiÞ ¼ EðvijXi;SiÞ;
(iii) rank EðX0iR
0SiRXiÞ ¼ K ;
(iv) Eðviv0i jXi;SiÞ ¼ X, whereX¼R
1ðR0Þ1. Assu-
ming X is positive definite, R can be
taken as the unique G G lower triangular,
nonsingular matrix with positive diagonal
elements.
As with the POLS, a random effect analysis,
puts ai into the error term and imposes more
restrictive assumptions. The random effect ap-
proach exploits the serial correlation in the
composite error in a generalized least squares
(GLS) framework. In order to ensure feasible GLS
is consistent under exogenous censoring, we need
assumption 2(i)–(iv).
Typically, we would assume that X has the
standard random effects form. This standard
random effect form is X ¼ s2uIG þ s
2
ajGj
0
G, where
Eðu2igÞ ¼ s
2
u, Eða
2
i Þ ¼ s
2
a, IG is G G identity
matrix and jGj
0
G is the G G matrix with unity in
every element. There is a simple analytical form
for R when X has the random effect form. To see
this, define zg ¼ f½ðgs2a þ s
2
uÞ=½ðgþ 1Þs
2
as
2
u þ s
4
ug
1=2
for g ¼ 1; 2; . . . ;G and z0 ¼ ½1=ðs2a þ s
2
uÞ
1=2. Then
R can be written as:
zG1 0   
 s
2
azG1
ðG1Þs2aþs2u
zG2 0   
..
.
 s
2
azG2
ðG2Þs2aþs2u
. .
.
..
.
z0
0
BBBBBBB@
1
CCCCCCCA
However, this standard random effect form
assumption on X is not necessary for the following
theoretical development. We can transform
Equation (5) to
yni ¼ X
n
i bþ v
n
i
where yni ¼ Ryi;X
n
i ¼ RXi and v
n
i ¼ Rvi.
The reason why we choose R as a lower
triangular matrix is due to the attrition problem.
Note that ðxig; yigÞ is observed if and only if
ðxig; yigÞ and ðxis; yisÞ are observed, s5g. Therefore
because R is lower triangular, ðxnig; y
n
igÞ is observed
if and only if ðxig; yigÞ is observed. Then SiXni is
observed. This would not be true if we do not
choose R lower triangular, or if we have other
patterns of missing data.
Using this set-up, we obtain the unweighted
GLS estimator of b
#bur ¼ N1
XN
i¼1
Xn
0
i SiX
n
i
 !1
N1
XN
i¼1
Xn
0
i Siy
n
i
 !
ð6Þ
Obtaining GLS requires knowing X up to scale. In
feasible GLS (FGLS) estimation, we replace the
unknown matrixX with a consistent estimator and
get asymptotic properties that are identical to
those of the GLS estimator. For example, under
the standard random effects form assumption, we
can replace s2a and s
2
u with their consistent
estimators, respectively,
#s2a ¼
1
½NGðG 1Þ=2 K 
XN
i¼1
XG1
g¼1
XG
s¼gþ1
*uig *uis ð7Þ
#s2u ¼
1
½NG K 
XN
i¼1
XG
g¼1
*u2ig
 !
 #s2a ð8Þ
where *uig is the estimated ith POLS residual at the
gth interval.
This estimator is feasible and the consistency of
#bur follows under assumption 2(i)–(iv). Explicitly,
by the usual law of large numbers argument, and
by using Equation (6)
p lim #bur ¼ ½EðX0iR
0SiRXiÞ1EðX0iR
0SiRyiÞ ¼ b
To obtain the asymptotic variance of #bur, let
Aur ¼ EðX0iR
0SiRXiÞ, and write
ffiffiffiffi
N
p
ð #bur  bÞ ¼ A1ur N
1=2
XN
i¼1
X0iR
0SiRvi
 !
þ opð1Þ ð9Þ
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The asymptotic variance of the bracketed term in
(9) is EðXn
0
i SiRviv
0
iR
0SiX
n
i Þ. Under assumption 2(iv)
this reduces to Aur. This shows that the asymptotic
variance of the LHS of Equation (9) can be
estimated by
#Vur ¼ N1
XN
i¼1
X0iR
0SiRXi
 !1
ð10Þ
assuming that we know R. Otherwise, assuming
the standard form ofX and the derived form R, (7)
and (8) produce an estimate of R.
Correlation between the survival times and
medical costs would violate exogenous censoring
assumption 2(ii), making #bur inconsistent. Inverse
probability weighted estimation produces consis-
tent and
ffiffiffiffi
N
p
asymptotically normal estimators
even under violation of the assumption 2(ii) if the
following assumptions hold.
Assumption 20.
(i) EðXn
0
i v
n
i Þ ¼ 0;
(ii) EðXn
0
i X
n
i ) has rank K ;
(iii) xig and yig are ignorable in the selection
equation, that is,
Pðsig ¼ 1jXi; yi;TiÞ ¼ Pðsig ¼ 1jTiÞ
¼PðCi  TnigjTiÞ
As in the case of POLS, another advantage of
weighting the observations, other than solving the
censoring problem is that we derive consistency
with the weaker assumption 20(i) rather than
assumption 2(i). Assumption 20(ii) is the appro-
priate rank condition. In terms of conditioning set,
assumption 20(iii) is much stronger than the one
presented under POLS section. Write *Si ¼ SiP1i .
Using this set-up, IPW RE estimator is
#bwr ¼ N1
XN
i¼1
Xn
0
i
*SiX
n
i
 !1
N1
XN
i¼1
Xn
0
i
*Siy
n
i
 !
We can estimate R by using IPW POLS residuals
in Equations (7) and (8), assuming the selection
probabilities in Pi are known or can be estimated.
This makes the estimator feasible. To derive the
consistency of #bwr write
#bwr¼ N1
XN
i¼1
X0iR
0 *SiRXi
 !1
N1
XN
i¼1
X0iR
0 *SiRyi
 !
By the usual law of large numbers argument
p lim #bwr ¼ ½EðX0iR
0 *SiRXiÞ1EðX0iR
0 *SiRyiÞ
But the usual iterated expectations argument gives
EðX0iR
0 *SiRXiÞ ¼E½X0iR
0Eð *Si jXi; yiÞRXi
¼E½X0iR
0RXi
¼E½X0iX
1Xi
Essentially the same argument gives
EðX0iR
0 *SiRyiÞ ¼ E½X
0
iX
1yi. Therefore, under the
assumption 2(i) and obvious rank condition
assumption rank EðX0iX
1XiÞ ¼ K
p lim #bwr ¼ E½X0iX
1Xi1E½X0iX
1yi ¼ b
To obtain the asymptotic variance of #bwr let
Awr ¼ EðX0iX
1XiÞ, and writeffiffiffiffi
N
p
ð #bwr  bÞ ¼ A1wr N
1
XN
i¼1
X0iR
0 *SiRvi
 !
þ opð1Þ
Then
A var½
ffiffiffiffi
N
p
ð #bwr  bÞ ¼ A
1
wr BwrA
1
wr
where Bwr ¼ EðX0iR
0 *SiRviv
0
iR
0 *SiRXiÞ. Both Awr and
Bwr can be consistently estimated, and there are no
simplifications even under all the assumptions of
the random effects model in the population. The
estimated asymptotic variance of IPW RE estima-
tor is, therefore,
#Vwr ¼ N1
XN
i¼1
X0iR
0 *SiRXi
 !1
 N1
XN
i¼1
X0iR
0 *SiR#vi #v
0
iR
0 *SiRXi
 !
 N1
XN
i¼1
X0iR
0 *SiRXi
 !1
ð11Þ
where #vi ¼ y
n
i  X
n
i
#bwr.
As in the case of POLS, except when the
censoring is exogeneous, #Vwr is unadjusted, be-
cause the estimation of Pi at the first stage has not
been accounted for. The adjusted variance matrix
can be obtained by applying the results from
Appendix A. Usually, the adjustment for estima-
tion at the first step has little effect on the
asymptotic standard errors.
As mentioned previously, our cost vector yi may
include zero components. With RE model, the
linear transformation SiR is applied to the vector
yi in the unweighted case, and SiP
1
i R is used in
the weighted case. In both situations, it is very
O. Bas,er et al.518
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unlikely in practice to have many zeros values in
the final analysis vector SiRyi or SiP
1
i Ryi. The
asymptotic theory of the estimators #bur and #bwr is
still valid. However, this does not say anything
about how good the model fit would be.
The cost of treating patients who have died
usually accelerate as the patient gets closer to
death. Since our model allows for estimating cost
in a period among those who died relative to those
survived, we only need to add a time by death
status interaction term. Costs of those who die in a
period can be compared with costs of those who
survived that period. These same groups can also
be compared for the period before death. To
model this we need: (i) intercept, (ii) period
indicator, (iii) interaction of period and death
indicators.
Weighted or unweighted estimator?
It has been shown that the unweighted estimator is
no less efficient than the weighted estimator under
homoskedasticity and exogenous censoring [7].
For a linear regression model, the Gauss–Markov
Theorem for independent observations implies
that the OLS estimator is the best linear unbiased
estimator. It is better than any other weighted
estimator, which is linear and unbiased.
Because the unweighted estimator is inconsistent
when the censoring scheme is not exogenous and
the weighted estimator is consistent with or
without exogenous censoring, we can apply a
Hausman test [13] to determine exogeneity of
censoring. The traditional form of Hausman
statistics can be used under the homoskedasticity
assumption. We can state this assumption for the
POLS estimator as follows:
Eð *X0i*ui*u
0
i
*XiÞ ¼ s20Eð *X
0
i
*XiÞ ð12Þ
When Equation (12) holds, estimation of the
unweighted POLS variance estimator is simplified
further
#Vup ¼ #s2 #A1up ð13Þ
provided we have a consistent estimator #s2 of s20.
In general form, the Hausman test statistic can
be stated as
H ¼ ð #hw  #huÞ
0 #V1ð #hw  huÞ
The distribution of H under the null hypothesis
is chi-square with K degrees of freedom. For
weighted and unweighted POLS, choose #hw, #hu as
#bwp, #bup, respectively. #V  #Vw  #Vu, where #Vw
is given by (3) and #Vu by (13) under the
homoskedasticity assumption.
For the RE model, #hw and #hu are #bwr and #bur,
respectively. #Vw is given by (11) and #Vu by (10). In
many cases we may want to use a Hausman test
when the homoskedasticity assumption is violated.
This requires a robust form that replaces #V for
POLS estimation by
ð #A1wp j  #A
1
up Þ N
1
XN
i¼1
XG
g¼1
#eig #e
0
ig
 !
ð #A1wp j  #A
1
up Þ
0=N
where ð:j:Þ denotes the augmented matrix obtained
by appending two matrices and #eig ¼ ð #wig #uigx0ig;
sig *uigx
0
igÞ
0. #uig and *uig are the residuals after
weighted and unweighted POLS estimation. For
RE estimation, we replace #V by
ð #A1wr j  #A
1
ur Þ N
1
XN
i¼1
*ei*e
0
i
 !
ð #A1wr j  #A
1
ur Þ
0=N ð14Þ
where *ei ¼ ðX0iR
0 *SiRXi #vi;X
0
iR
0SiRXi*viÞ
0, and #vi; *vi
are the residuals after weighted and unweighted
RE estimation.
If the Hausman test indicates rejection, then the
assumption of exogenous censoring is violated,
and the unweighted estimators are inconsistent.
A failure to reject means the coefficients from
unweighted and weighted estimators are not
systematically different. The typical response is to
conclude that the exogeneity assumption holds
and therefore, we should use OLS estimates.
Unfortunately due to the low power of the
Hausman test we might commit a Type II error.
Therefore, it is recommended that the results from
both estimations be presented.
The lung cancer study
Data
The data set is derived from a broader study of
health care cost, utilization and physical health
function in a cohort of newly diagnosed elderly
lung cancer patients recruited from several Michi-
gan oncology clinics during 1994 through 1997.
For our application, we use data from 201 (out of
223) Medicare beneficiaries age 65 or older who
agreed to participate in this study. We excluded 22
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patients because their demographic data was
missing. Detailed cost data were obtained from
Medicare claim files for each patient for a 2-year
period following diagnosis. Payments by Medicare
were used as a proxy for direct Medicare costs
(as opposed to billed charges).
Patient demographic data were obtained
through interviews. Physical function 3 months
prior to diagnosis was measured by the short form
SF-36. The physical function subscale of the SF-36
[17] is a 10 item measure of patients ability to
perform a series of ordered activities including
lifting, bending, stooping, and carrying packages
of a given weight, walking different distances, and
climbing stairs and performing self care activities
such as dressing and bathing oneself. The scale is a
weighted sum score with 100 representing high
level of functioning and lower scores indicating
persons who are less able to perform physical
activities. Comorbid conditions were assessed
using questions from the Aging and Health in
America Survey (1996), which documents 15
Table 1. Summary statistics from the lung cancer study
Variable Variable description Mean ðN ¼ 4335Þ
Total cost Total medicare payments $2620P
(Inpatient, Outpatient, Provider) ($7175)
Age Patient’s age within two weeks of 71.97
initiating either radiation or chemotherapy (4.85)
Physical functioning Three months prior to diagnosis 72.10
using the subscale from the SF-36 (27.30)
Symptoms A count of all symptoms 10.87
(4.99)
Comorbidity ¼ 1 if patient’s comorbid 0.65
conditions are three or more (0.48)
Late stage ¼ 1 if patient’s disease 0.64
stage is regional, distant or invasive (0.48)
White ¼ 1 if patient’s race is white 0.93
stage is regional, distant or invasive (0.27)
Male ¼ 1 if patient’s gender is male 0.59
stage is regional, distant or invasive (0.49)
Pays all ¼ 1 if insurance coverage pays all expenses 0.40
(0.49)
Pays more ¼ 1 if insurance coverage requires minor expenses 0.48
(0.50)
Pays little ¼ 1 if insurance coverage requires many expenses 0.09
(0.29)
Pays none ¼ 1 if many services are not covered 0.03
(0.17)
No treatment ¼ 1 if patient received 0.8104
no treatment (0.3920)
Surgery ¼ 1 if patient received 0.01407
surgery only (0.1178)
Surgery & Chemo ¼ 1 if patient received 0.0005
surgery and chemotherapy (0.2147)
Surgery & Radiation ¼ 1 if patient received 0.0002
surgery and radiation (0.0151)
Surgery & Chemo & Radiation ¼ 1 if patient received 0.0018
surgery, chemotherapy and radiation (0.0429)
Chemo & Radiation ¼ 1 if patient received 0.0209
chemotherapy and radiation (0.1434)
Chemotherapy ¼ 1 if patient received 0.0911
chemotherapy only (0.2878)
Radiation ¼ 1 if patient received 0.0609
radiation only (0.2392)
Standard deviations are in parentheses.
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diseases and health problems other than lung
cancer. Disease stage was determined by the
Tumor Nodes and Metastasis (TNM) staging
system of the American Joint Committee on
Cancer (AJCC) using the pathological data
obtained from audit of patients’ medical records.
Table 1 shows the summary statistics for each
variable as well as short description of the variables.
A patient’s medical cost was regarded as
censored if the patient was alive at the end of
1997 and if follow up was less than two years.
Because censoring is solely due to the limit of study
duration, it is reasonable to assume that censoring
is independent of all other random variables.
Figure 1 shows the distribution of average
monthly costs for uncensored cases. Expenditure
shows a spike in the first month after diagnosis due
to surgery. Interventions such as surgery and
radiation incur large costs within the first few
months of following diagnosis, whereas che-
motherapy, which is less costly, may be adminis-
tered over a much longer time.
Regression analysis
Two analyses were performed to examine how
patient- and treatment-related variables explain
total medical cost for older persons newly diag-
nosed with lung cancer. In particular, we are
interested in how various treatment regimens (e.g.
surgery only, chemotherapy, radiation, and com-
binations of surgery, chemotherapy, and radia-
tion) affected the total cost of lung cancer care.
Total medical cost is the expenditure incurred
from initiation of treatment until death or for a
2-year period, whichever comes first. Monthly
expenditures were derived for this period. Follow-
ing Manning and Mullahy [18] the cost estimates
satisfied conditions for which an OLS-based model
for log-transformed dependent variable was
appropriate. One of the disadvantages of log-
transformed models are zero cost observations.
We did not have zero-cost as long as the individual
was alive. Since we are considering total cost, some
cost would be observed even there is no treatment.
We did have a zero cost issue, if an individual died.
In our sample, however, only 5 patients out of 201
died during the study period. We assumed that
these patients had a cost of $1 per month,
following the month death, so that when we
transformed cost into its natural log, the cost per
month would then be 0. If the percentage of
patients died was higher, we would have used
generalized linear model (GLM) approach sug-
gested by Manning et al. [19]. Table 2 shows the
results of the regression analysis for correlates of
the total cost.
Because the population may have a different
distribution in different periods we allowed the
intercept to differ across different months. These
are the time dependent factors. The first month
after diagnosis was the base month and dummy
variables were added for all other months. The
estimated coefficients were all negative and statis-
tically significant ðp50:05Þ. (These results are not
shown).
The control variables include time independent
covariates such as gender, race, comorbid condi-
tions, stage of cancer and physical functions and
time dependent covariates such as age and treat-
ment-related variables. We divided treatment into
seven categories: no treatment, radiation only,
chemotherapy only, surgery and radiation, surgery
and chemotherapy, chemotherapy and radiation,
and finally surgery, chemotherapy and radiations.
The latter was chosen as the reference group.
In our sample, all subjects are enrolled in
Medicare and thus insurance payer is exogenous.
Researchers using data from subjects that have
other forms of insurance (or are uninsured) may
want to include insurance payer as an explanatory
variable.
Disease severity, as measured by cancer stage,
had a statistically significant effect under both
IPW RE and IPW POLS models. Regional stage
decreased total cost of care almost 68% according
to IPW POLS and 41% according to IPW RE
compared to in situ or local stage cancer.
On average, expenses for patients who had no
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0
2000
4000
6000
8000
10000
12000
14000
16000
18000
Months
$
Figure 1. The distribution of average monthly cost values for
uncensored cases
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treatment were almost 99% less than for the
patients who had surgery chemotherapy and
radiation according to the IPW POLS and 4.46
times greater according to IPW RE models. A
person who received radiation only had decreased
the total medical cost relative to the average cost
for persons with surgery plus adjuvant therapies.
The estimates with respect to IPW POLS and IPW
RE are 72 and 49%.
The Hausman test comparing the POLS
and IPW POLS, and RE and IPW RE models,
suggest that the exogenous censoring assumption
is not violated. Thus, coefficients from weighted
and unweighted estimations are both consistent.
Conclusion
Measurement of treatment cost is especially
important in the evaluation of medical interven-
tions, in the analysis of clinical trials, and in social
Table 2. Estimates of the log transformed total medical cost
POLS IPWPOLS RE IPWRE
Variable n ¼ 4335 n ¼ 4335 n ¼ 4335 n ¼ 4335
Age 0.0044 0.0038 0.033 0.05342
(0.0183) (0.0184) (0.01911) (0.02196)
Physical functioning 0.0031 0.0024 0.0019 0.0065
(0.0035) (0.0035) (0.0039) (0.0042)
Symptoms 0.0013 0.0027 0.0004 0.006
(0.0191) (0.0193) (0.0205) (0.0228)
Comorbidity 0.2053 0.2293 0.0204 0.3271
(0.1989) (0.1996) (0.2054) (0.2205)
Late stage 1.1153 1.1887 1.0626 1.1212
(0.2049)nn (0.2086)nn (0.2040)nn (0.2301)nn
White 0.1955 0.2289 0.0306 0.1614
(0.3812) (0.3752) (0.4511) (0.4803)
Male 0.1843 0.1846 0.1691 0.1299
(0.1915) (0.1946) (0.1944) (0.2144)
Pays more 0.1746 0.1783 0.1243 0.0471
(0.1993) (0.2004) (0.3651) (0.2277)
Pays little 0.1817 0.1492 0.2696 0.1446
(0.3717)nn (0.3863)nn (0.3651)nn (0.4358)nn
Pays none 0.4758 0.5136 0.5501 0.9925
(0.3911) (0.4073) (0.3889) (0.5359)
Surgery 5.7724 5.7976 5.3409 5.4178
(0.2084) (0.2098) (0.2678) (0.2691)
Surgery & Chemo 4.8626 4.8787 5.0051 5.1912
(0.7230) (0.7176) (0.5007) (0.4546)
Surgery & Chemo & Radiation 6.3000 6.3184 3.8124 3.8299
(0.4585) (0.4523) (0.2067) (0.20695)
Surgery & Radiation 5.7719 5.7822 5.7458 5.8515
(0.2959) (0.2989) (0.3572) (0.3705)
Chemo & Radiation 5.7356 5.7774 5.4732 5.5766
(0.1936) (0.1937) (0.2273) (0.2299)
Chemotheraphy 5.2680 5.3257 4.7609 4.8458
(0.1768)nn (0.1792)nn (0.1787) (0.1832)
Radiation 4.8976 4.9337 4.6567 4.7324
(0.1804)nn (0.1807)nn (0.1879)n (0.1877)n
Constant 5.2925 5.2426 5.6180 5.7946
(1.6023)nn (1.5999)nn (1.7307)nn (1.9492)nn
Monthly dummies Yes Yes Yes Yes
R-squared 0.7179 0.7305 0.7512 0.7564
Robust standard errors in parentheses nsignificant at 5%; nnsignificant at 1%.
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experiments. However, because cost records are
incomplete, it is difficult to estimate cost accu-
rately. Current statistical methods that would be
applicable to administrative data, which is often
censored, are under-developed.
One advantage of cost data is that they often fit
naturally into a panel data format. This paper
estimates medical cost per patient as a linear
function of time varying covariates over a time
interval ½0;L following diagnosis. This interval is
divided into G periods, so a panel structure arises.
Censoring (in some periods) occurs when, for a
given patient, the follow-up time is smaller than L
and smaller than the survival time of the patient.
The IPW least squares method was applied to
longitudinal data to illustrate how possible cen-
soring bias can be removed. The main motivation
for developing the method is to handle a large
number of continuous and discrete covariates.
We analyzed POLS and RE models and
examined their statistical properties under censor-
ing. Without exogenous censoring, the usual
POLS and RE estimators are inconsistent. Gen-
erally, censoring is not exogenous because per-
period medical cost may not be independent of
survival time and the later is not independent of
whether or not censoring occurs. To correct for
censoring bias, we propose using IPW estimators,
either in a pooled OLS or in a random effects
framework. IPW estimators are consistent andffiffiffiffi
N
p
asymptotically normal. We also derived these
estimators’ first stage adjusted variance matrix.
Since unweighted POLS and RE estimators are
consistent under exogenous censoring and more
efficient under the homoskedasticity assumption,
the Hausman test can be used to compare the
systematic differences in coefficients between
weighted and unweighted estimators. This test
can be use to ascertain whether the exogenous
censoring assumption is violated and whether the
censoring bias creates statistically meaningful
differences in the coefficients. We also derived
and applied robust forms of the Hausman test in
case the homoskedasticity assumption is violated.
Although it does not demonstrate the full power
of the IPW least squares method, the lung cancer
study demonstrated our proposed regression
methods and test statistics. We fail to reject the
hypothesis that the exogenous censoring assump-
tion is violated. In order to see that this assump-
tion was not violated in the lung cancer example,
we needed to apply IPW estimation. Thus while
the censoring bias created by applying POLS or
RE on complete observations does not produce
statistically different results than IPW POLS and
IPE RE produce, though the latter two do correct
for possible censoring bias.
One of the problems with medical cost data is
fraction of zeros. This is especially dominant when
we analyze subcategory costs such as inpatient
costs. In order to deal with skewness generalized
linear models (GLM) are proposed by several
authors [18–20]. Especially with cost-per-indivi-
dual per month analysis, those without the disease
will have even higher fraction of zeroes than
they do for annual data. Further, the subperiod
data on positive expenditures will be even more
skewed than is the case for annual data. Here, we
are faced with the robustness-efficiency trade-off,
which is very common in econometrics. Our
analysis is probably more efficient with monthly
data, but less robust than an analysis that uses just
annual data. Although we focus on log-trans-
formed OLS on modeling medical cost data, the
present framework can be adapted to GLM
models to deal with both zeroes and skewness
assuming that the correct link function is known
or is estimable.
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Appendix A: Derivation of IPW POLS
Variance Matrix adjusted to ¢rst stage
estimation of censoring probabilities
Let
##b be IPW POLS estimator
##bwp ¼ N1
XN
i¼1
XG
g¼1
sigxigx
0
ig
#pig
 !1
 N1
XN
i¼1
XG
g¼1
sigxigyig
#pig
 !
ðA1Þ
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where #pig is defined in Equation (4) in the main
text. It is convenient to express #pig as pðTnig; #yÞ,
where #y is the vector of estimated parameters that
appear in the first stage estimation. As mentioned
in the text, consistency of
##bwp be easily read off
from (A1) by using Lemma 4.3 in Newey and
McFadden [15] under usual assumption. In the
application here, we need to obtain the asymptotic
variance of
ffiffiffi
n
p
ð##bwp  bwpÞ when pig’s are estimated
in the preliminary stage.
By substituting for yig, (A1) can be re-written as
ffiffiffi
n
p
ð##bwpbwpÞ¼ N
1
XN
i¼1
XG
g¼1
sigxigx
0
ig
pðTnig; #yÞ
 !1
 N1=2
XN
i¼1
XG
g¼1
sigxiguig
pðTnig; #yÞ
 !
ðA2Þ
Applying the uniform law of large numbers
(Lemma 4.3 of Newey and McFadden [15]) shows
that the first term on the right-hand side of (A2)
converges to
E
XG
g¼1
sigxigx
0
ig
pðTnig; y0Þ
 !
¼ E
XG
g¼1
xigx
0
ig
 !
¼ Aw ðA3Þ
where y0 is the true parameter. Standard max-
imum likelihood estimation is used to estimate
y0 by #y. The part of the likelihood of ðZi; siÞ
that is relevant for estimation of y has the
form fpðZi; yÞg
sifgðZi; yÞg
1si fpðtG; yÞg½T ^ C > tg
where gðt; yÞ is a density for Ci. We need to assume
that pðtG; yÞ > 0 and that y! gð:; yÞ to fulfill all
regularity conditions needed for maximum like-
lihood estimation of y.
Note that zi 2 ðtg1; tg and si ¼ 1 is equivalent
to ½Ci  Tnig½tg1  T
n
ig5tg ¼ sigIgðT
n
igÞ, whereas
zi 2 ðtg1; tg and si ¼ 0 is equivalent to
½tg1  Ci5Tnig ¼ ð1 sigÞIgðCiÞ, where IgðtÞ ¼
½tg1  t5tg: To include the interval t tG,
define the indicator IGþ1ðtÞ ¼ ½t tG. Then the
derivative with respect to y of the aforementioned
log-likelihood can be writtenXG
i¼1
sigIgðTnigÞ
rypðTnig; yÞ
pðTnig; yÞ
þð1sigÞIgðCiÞ
rygðCi; yÞ
gðCi; yÞ
(
þð1=GÞIGþ1ðTi ^ CiÞ
rypðL; yÞ
pðL; yÞ

¼
XG
i¼1
digðyÞ
The estimator #y is a solution
PN
i¼1
PG
i¼1 digðyÞ ¼ 0.
Consistency of #y follows from the standard
regularity conditions on the function y! gð:; yÞ
for maximum likelihood estimation of y.
Let y0 be the true parameter. Note that digðy0Þ
is a q 1 vector. Using a Taylor expansion ofPN
i¼1
PG
i¼1 digð#yÞ ¼ 0 at y0, one can showffiffiffi
n
p
ð#y y0Þ
¼ J1ðy0Þ
ffiffiffiffi
N
p XN
i¼1
XN
g¼1
digðy0Þ
 !
þ opð1Þ ðA4Þ
where Jðy0Þ ¼ Eð
PG
g¼1 digðy0ÞÞð
PG
g¼1 d
0
igðy0ÞÞ is a
q q matrix.
By using the standard asymptotic representation
of a maximum likelihood estimator based on the
information matrix equality and (A4), we can
write the second term on the right-hand side of
(A2) to get
N1=2
XN
i¼1
XG
g¼1
sigxigu
0
ig
pðTnig; #yÞ
¼ N1=2
XN
i¼1
fki Dðy0ÞJ1ðy0Þdiðy0ÞjGg þ opð1Þ ðA5Þ
where diðy0Þ ¼ ½di1ðy0Þ; . . . ; diGðy0Þ is a q G
matrix, jG is a G 1 vector of 1’s, and Dðy0Þ ¼
Eð
PN
i¼1
PG
g¼1
sigxiguig
ðpðTn
ig
;*yÞÞ2
ðrypðTnig; y0ÞÞ
0Þ is a K  q
matrix, and ki ¼
PG
g¼1
sigxigu
0
ig
pðTn
ig
;y0Þ
is a K  1 vector.
Combining the terms, (A2) can be re-written as
ffiffiffi
n
p
ð##bwpbwpÞ ¼ A
1
w N
1=2
XN
i¼1
ei
 !
þ opð1Þ ðA6Þ
where ei ¼ ðki Dðy0ÞJ1ðy0Þdiðy0ÞjGÞ. A direct
calculation of the variance matrix of the right-
hand side of (A6) shows that
ffiffiffi
n
p
ð##b bwÞ has
asymptotic variance Vwa ¼ A
1
w FwA
1
w where
Fw ¼ Eðkik0iÞ Dðy0ÞJ
1ðy0ÞD0ðy0Þ.
Under exogenous censoring (see assumption 1)
we get Dðy0Þ ¼ 0 and so the asymptotic variance
reduces to Vwa ¼ A
1
w Eðkik
0
iÞA
1
w which is the
asymptotic variance matrix of #bwp in the main text
(see (3)). This is the variance if the censoring
probabilities were known. In general, the differ-
ence Vwa  Vwu is negative definite which makes
the asymptotic variance after first stage estimation
no larger than that if the first stage was ignored.
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